To reduce the risk of stroke, the WATCHMAN™ left atrial appendage closure (LAAC) device has provided an additional option for some patients with non-valvular atrial fibrillation who are not good candidates for long-term anticoagulation therapy. Now, studies are underway to investigate the effectiveness of this device in a wider patient pool.